Ultralife Corporation (ULBI) is a publicly traded Industrials sector company. As of July 24, 2026, ULBI trades at $5.38 with a market cap of $90.70M and a P/E ratio of -0.14. ULBI moved -0.64% today. Year to date, ULBI is -5.94%; over the trailing twelve months it is -40.22%. Its 52-week range spans $4.07 to $9.52. Rallies surfaces ULBI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ULBI, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $5.38 |
| Market Cap | $90.70M |
| P/E Ratio | -0.14 |
| EPS | $-38.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.52 |
| 52-Week Low | $4.07 |
| Volume | 12.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $187.86M |
| Net Income | $-8.30M |
| Gross Margin | 23.09% |
ULBI analyst coverage data. Average price target: $0.00.